Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
5.99
+0.04 (0.67%)
At close: Dec 5, 2025, 4:00 PM EST
6.05
+0.06 (0.97%)
After-hours: Dec 5, 2025, 8:00 PM EST
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
298.92M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CYBN News
- 22 days ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire
- 24 days ago - Cybin to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
- 4 weeks ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire
- 4 weeks ago - Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 4 weeks ago - Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Business Wire
- 5 weeks ago - Cybin Announces Closing of $175 Million Registered Direct Offering - Business Wire
- 5 weeks ago - Cybin Announces $175 Million Registered Direct Offering - Business Wire